Biden Looks to Beef up US Biomanufacturing Amid Pressure From China
The Biden Administration, after setting its sights on America’s pharmaceutical supply chains last winter, is telegraphing its next move to restore the United States’ drugmaking prowess.
President Joe Biden penned an executive order Monday to boost biotechnology and biomanufacturing across a range of areas in the U.S.
To help the U.S. biotech sector reach its full potential, the U.S. needs to funnel cash toward development of genetic engineering tech, use approaches like artificial intelligence to “unlock the power of biological data,” and “scale-up production,” whilst simultaneously breaking down obstacles to commercialization so that innovative products can hit the market faster, Biden said in a White House release.
Read the full article at: www.fiercepharma.com
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
